BindingDB logo
myBDB logout

BDBM5101 1,2,4-Oxadiazole Analogue 13a::4-[(2S)-2-acetamido-2-{[(1S)-3-phenyl-1-(3-{[4-(trifluoromethyl)phenyl]methyl}-1,2,4-oxadiazol-5-yl)propyl]carbamoyl}ethyl]phenoxyphosphonic acid

SMILES: CC(=O)N[C@@H](Cc1ccc(OP(O)(O)=O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(cc2)C(F)(F)F)no1

InChI Key: InChIKey=QMRZIGJBOKWGSJ-UIOOFZCWSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 5101   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase ZAP-70


(Homo sapiens (Human))
BDBM5101
PNG
(1,2,4-Oxadiazole Analogue 13a | 4-[(2S)-2-acetamid...)
Show SMILES CC(=O)N[C@@H](Cc1ccc(OP(O)(O)=O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(cc2)C(F)(F)F)no1 |r|
Show InChI InChI=1S/C30H30F3N4O7P/c1-19(38)34-26(17-21-9-14-24(15-10-21)44-45(40,41)42)28(39)35-25(16-11-20-5-3-2-4-6-20)29-36-27(37-43-29)18-22-7-12-23(13-8-22)30(31,32)33/h2-10,12-15,25-26H,11,16-18H2,1H3,(H,34,38)(H,35,39)(H2,40,41,42)/t25-,26-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 5.00E+3n/an/an/an/an/an/a



ARIAD Pharmaceuticals, Inc.



Assay Description
Fluorescence polarization competitive binding assays were used to measure the IC50s of compounds binding to the different SH2 domains. The difference...


J Med Chem 42: 4088-98 (1999)


Article DOI: 10.1021/jm990229t
BindingDB Entry DOI: 10.7270/Q27D2SBP
More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM5101
PNG
(1,2,4-Oxadiazole Analogue 13a | 4-[(2S)-2-acetamid...)
Show SMILES CC(=O)N[C@@H](Cc1ccc(OP(O)(O)=O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(cc2)C(F)(F)F)no1 |r|
Show InChI InChI=1S/C30H30F3N4O7P/c1-19(38)34-26(17-21-9-14-24(15-10-21)44-45(40,41)42)28(39)35-25(16-11-20-5-3-2-4-6-20)29-36-27(37-43-29)18-22-7-12-23(13-8-22)30(31,32)33/h2-10,12-15,25-26H,11,16-18H2,1H3,(H,34,38)(H,35,39)(H2,40,41,42)/t25-,26-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.23E+5n/an/an/an/an/an/a



ARIAD Pharmaceuticals, Inc.



Assay Description
Fluorescence polarization competitive binding assays were used to measure the IC50s of compounds binding to the different SH2 domains. The difference...


J Med Chem 42: 4088-98 (1999)


Article DOI: 10.1021/jm990229t
BindingDB Entry DOI: 10.7270/Q27D2SBP
More data for this
Ligand-Target Pair
Grb2-SH2


(Homo sapiens (Human))
BDBM5101
PNG
(1,2,4-Oxadiazole Analogue 13a | 4-[(2S)-2-acetamid...)
Show SMILES CC(=O)N[C@@H](Cc1ccc(OP(O)(O)=O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(cc2)C(F)(F)F)no1 |r|
Show InChI InChI=1S/C30H30F3N4O7P/c1-19(38)34-26(17-21-9-14-24(15-10-21)44-45(40,41)42)28(39)35-25(16-11-20-5-3-2-4-6-20)29-36-27(37-43-29)18-22-7-12-23(13-8-22)30(31,32)33/h2-10,12-15,25-26H,11,16-18H2,1H3,(H,34,38)(H,35,39)(H2,40,41,42)/t25-,26-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>5.00E+5n/an/an/an/an/an/a



ARIAD Pharmaceuticals, Inc.



Assay Description
Fluorescence polarization competitive binding assays were used to measure the IC50s of compounds binding to the different SH2 domains. The difference...


J Med Chem 42: 4088-98 (1999)


Article DOI: 10.1021/jm990229t
BindingDB Entry DOI: 10.7270/Q27D2SBP
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM5101
PNG
(1,2,4-Oxadiazole Analogue 13a | 4-[(2S)-2-acetamid...)
Show SMILES CC(=O)N[C@@H](Cc1ccc(OP(O)(O)=O)cc1)C(=O)N[C@@H](CCc1ccccc1)c1nc(Cc2ccc(cc2)C(F)(F)F)no1 |r|
Show InChI InChI=1S/C30H30F3N4O7P/c1-19(38)34-26(17-21-9-14-24(15-10-21)44-45(40,41)42)28(39)35-25(16-11-20-5-3-2-4-6-20)29-36-27(37-43-29)18-22-7-12-23(13-8-22)30(31,32)33/h2-10,12-15,25-26H,11,16-18H2,1H3,(H,34,38)(H,35,39)(H2,40,41,42)/t25-,26-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 9.50E+4n/an/an/an/an/an/a



ARIAD Pharmaceuticals, Inc.



Assay Description
Fluorescence polarization competitive binding assays were used to measure the IC50s of compounds binding to the different SH2 domains. The difference...


J Med Chem 42: 4088-98 (1999)


Article DOI: 10.1021/jm990229t
BindingDB Entry DOI: 10.7270/Q27D2SBP
More data for this
Ligand-Target Pair